FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 307:971-975 October 14, 1982 Number 16 Next

	Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

Abstract

We conducted a double-blind, placebo-controlled trial to assess the value of vidarabine therapy for the prevention of complications from herpes zoster in immunocompromised patients. Of 121 patients with localized herpes zoster of 72 hours duration or less, 63 received vidarabine and 58 received the placebo. Populations were matched for pertinent characteristics. Therapy accelerated cutaneous healing and decreased the rates of cutaneous dissemination (from 24 per cent [14 patients] to 8 per cent [5 patients]) (P = 0.014); and of zoster-related visceral complications (from 19 per cent [11 patients] to 5 per cent [3 patients]) (P = 0.015). therapy also decreased the total duration of post-herpetic neuralgia (P = 0.047). Patients with lymphoproliferative cancers and those 38 years of age or older were at greatest risk for complications and benefited most from therapy. There was no serious drug toxicity. We conclude that vidarabine therapy, when started within the first three days, is valuable for the reduction of complications related to herpes zoster.

This article has been cited by other articles:

• Hambleton, S., Gershon, A. A. (2005). Preventing Varicella-Zoster Disease. Clin. Microbiol. Rev. 18: 70-80 [Abstract] [Full Text]  
• Kimberlin, D. W. (2004). Neonatal Herpes Simplex Infection. Clin. Microbiol. Rev. 17: 1-13 [Abstract] [Full Text]  
• Cohen, J. I., Brunell, P. A., Straus, S. E., Krause, P. R. (1999). Recent Advances in Varicella-Zoster Virus Infection. ANN INTERN MED 130: 922-932 [Abstract] [Full Text]  
• Hammond, E. (1987). Herpes-Zoster Infections in Children with Hodgkin's Disease. Journal of Pediatric Oncology Nursing 4: 23-29  
• Dolin, R (1985). Antiviral chemotherapy and chemoprophylaxis. Science 227: 1296-1303 [Abstract]